Prophylactic Pediatric Vaccines Market Report

Europe Prophylactic Pediatric Vaccines Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 27, 2019
  • PAGES：138
  • REPORT CODE：GMM355657
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Prophylactic Pediatric Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.7% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Prophylactic Pediatric Vaccines Market Segmentations:

    By Player:

    • GlaxoSmithKline Plc (UK)

    • Sanofi Pasteur SA (France)

    • Bharat Biotech International Limited (India)

    • Hualan Biological Engineering Inc. (China)

    • Janssen Pharmaceuticals, Inc. (US)

    • Pfizer Inc. (US)

    • SK Chemicals Co., Ltd. (Korea)

    • ALK - Abello A/S (Denmark)

    • Altimmune, Inc (US)

    • Merck & Co., Inc. (US)

    • Altimmune, Inc. (US)

    • GlaxoSmithKline Plc. (UK)

    • BiondVax Pharmaceuticals Ltd. (Israel)

    • Shanghai BravoBio Co., Ltd. (China)

    • Serum Institute of India Pvt. Ltd. (India)

    • Seqirus (UK)

    • BiondVax Pharmaceuticals Ltd (Israel)

    • Shanghai BravoBio Co, Ltd (China)

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • End-User 1

    • End-User 2

    • End-User 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Prophylactic Pediatric Vaccines Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Prophylactic Pediatric Vaccines Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.2 Europe Prophylactic Pediatric Vaccines Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.3 Europe Prophylactic Pediatric Vaccines Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Prophylactic Pediatric Vaccines Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.2 Europe Prophylactic Pediatric Vaccines Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.3 Europe Prophylactic Pediatric Vaccines Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Prophylactic Pediatric Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Prophylactic Pediatric Vaccines by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Prophylactic Pediatric Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Prophylactic Pediatric Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Prophylactic Pediatric Vaccines for End-User 1

      • 4.4.2 Market Size and Growth Rate of Prophylactic Pediatric Vaccines for End-User 2

      • 4.4.3 Market Size and Growth Rate of Prophylactic Pediatric Vaccines for End-User 3

    5 Market Analysis by Major Regions

    • 5.1 Europe Prophylactic Pediatric Vaccines Production Analysis by Top Regions

    • 5.2 Europe Prophylactic Pediatric Vaccines Consumption Analysis by Top Regions

    • 5.3 Europe Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.3 France Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

    6 Product Circulation of Prophylactic Pediatric Vaccines Market among Top Countries

    • 6.1 Top 5 Export Countries in Prophylactic Pediatric Vaccines Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Prophylactic Pediatric Vaccines Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Prophylactic Pediatric Vaccines Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Prophylactic Pediatric Vaccines Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Prophylactic Pediatric Vaccines Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Prophylactic Pediatric Vaccines Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Prophylactic Pediatric Vaccines Landscape Analysis

    • 7.1 Germany Prophylactic Pediatric Vaccines Landscape Analysis by Major Types

    • 7.2 Germany Prophylactic Pediatric Vaccines Landscape Analysis by Major End-Users

    8. UK Prophylactic Pediatric Vaccines Landscape Analysis

    • 8.1 UK Prophylactic Pediatric Vaccines Landscape Analysis by Major Types

    • 8.2 UK Prophylactic Pediatric Vaccines Landscape Analysis by Major End-Users

    9. France Prophylactic Pediatric Vaccines Landscape Analysis

    • 9.1 France Prophylactic Pediatric Vaccines Landscape Analysis by Major Types

    • 9.2 France Prophylactic Pediatric Vaccines Landscape Analysis by Major End-Users

    10. Italy Prophylactic Pediatric Vaccines Landscape Analysis

    • 10.1 Italy Prophylactic Pediatric Vaccines Landscape Analysis by Major Types

    • 10.2 Italy Prophylactic Pediatric Vaccines Landscape Analysis by Major End-Users

    11. Spain Prophylactic Pediatric Vaccines Landscape Analysis

    • 11.1 Spain Prophylactic Pediatric Vaccines Landscape Analysis by Major Types

    • 11.2 Spain Prophylactic Pediatric Vaccines Landscape Analysis by Major End-Users

    12. Poland Prophylactic Pediatric Vaccines Landscape Analysis

    • 12.1 Poland Prophylactic Pediatric Vaccines Landscape Analysis by Major Types

    • 12.2 Poland Prophylactic Pediatric Vaccines Landscape Analysis by Major End-Users

    13. Russia Prophylactic Pediatric Vaccines Landscape Analysis

    • 13.1 Russia Prophylactic Pediatric Vaccines Landscape Analysis by Major Types

    • 13.2 Russia Prophylactic Pediatric Vaccines Landscape Analysis by Major End-Users

    14. Switzerland Prophylactic Pediatric Vaccines Landscape Analysis

    • 14.1 Switzerland Prophylactic Pediatric Vaccines Landscape Analysis by Major Types

    • 14.2 Switzerland Prophylactic Pediatric Vaccines Landscape Analysis by Major End-Users

    15. Turkey Prophylactic Pediatric Vaccines Landscape Analysis

    • 15.1 Turkey Prophylactic Pediatric Vaccines Landscape Analysis by Major Types

    • 15.2 Turkey Prophylactic Pediatric Vaccines Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Pediatric Vaccines Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Pediatric Vaccines Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Pediatric Vaccines Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Pediatric Vaccines Landscape Analysis by Top Countries

      • 16.3.1 Denmark Prophylactic Pediatric Vaccines Market Volume and Growth Rate

      • 16.3.2 Finland Prophylactic Pediatric Vaccines Market Volume and Growth Rate

      • 16.3.3 Norway Prophylactic Pediatric Vaccines Market Volume and Growth Rate

      • 16.3.4 Sweden Prophylactic Pediatric Vaccines Market Volume and Growth Rate

      • 16.3.6 Iceland Prophylactic Pediatric Vaccines Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Pediatric Vaccines Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Pediatric Vaccines Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Pediatric Vaccines Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Pediatric Vaccines Landscape Analysis by Top Countries

      • 17.3.1 Belgium Prophylactic Pediatric Vaccines Market Volume and Growth Rate

      • 17.3.2 Netherlands Prophylactic Pediatric Vaccines Market Volume and Growth Rate

      • 17.3.3 Luxembourg Prophylactic Pediatric Vaccines Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Pediatric Vaccines Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Pediatric Vaccines Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Pediatric Vaccines Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Pediatric Vaccines Landscape Analysis by Top Countries

      • 18.3.1 Estonia Prophylactic Pediatric Vaccines Market Volume and Growth Rate

      • 18.3.2 Latvia Prophylactic Pediatric Vaccines Market Volume and Growth Rate

      • 18.3.3 Lithuania Prophylactic Pediatric Vaccines Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 GlaxoSmithKline Plc (UK)

      • 19.1.1 GlaxoSmithKline Plc (UK) Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Sanofi Pasteur SA (France)

      • 19.2.1 Sanofi Pasteur SA (France) Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Bharat Biotech International Limited (India)

      • 19.3.1 Bharat Biotech International Limited (India) Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Hualan Biological Engineering Inc. (China)

      • 19.4.1 Hualan Biological Engineering Inc. (China) Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Janssen Pharmaceuticals, Inc. (US)

      • 19.5.1 Janssen Pharmaceuticals, Inc. (US) Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Pfizer Inc. (US)

      • 19.6.1 Pfizer Inc. (US) Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 SK Chemicals Co., Ltd. (Korea)

      • 19.7.1 SK Chemicals Co., Ltd. (Korea) Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 ALK - Abello A/S (Denmark)

      • 19.8.1 ALK - Abello A/S (Denmark) Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Altimmune, Inc (US)

      • 19.9.1 Altimmune, Inc (US) Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Merck & Co., Inc. (US)

      • 19.10.1 Merck & Co., Inc. (US) Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Altimmune, Inc. (US)

      • 19.11.1 Altimmune, Inc. (US) Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 GlaxoSmithKline Plc. (UK)

      • 19.12.1 GlaxoSmithKline Plc. (UK) Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 BiondVax Pharmaceuticals Ltd. (Israel)

      • 19.13.1 BiondVax Pharmaceuticals Ltd. (Israel) Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Shanghai BravoBio Co., Ltd. (China)

      • 19.14.1 Shanghai BravoBio Co., Ltd. (China) Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Serum Institute of India Pvt. Ltd. (India)

      • 19.15.1 Serum Institute of India Pvt. Ltd. (India) Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Seqirus (UK)

      • 19.16.1 Seqirus (UK) Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 BiondVax Pharmaceuticals Ltd (Israel)

      • 19.17.1 BiondVax Pharmaceuticals Ltd (Israel) Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Shanghai BravoBio Co, Ltd (China)

      • 19.18.1 Shanghai BravoBio Co, Ltd (China) Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    The List of Tables and Figures (Totals 68 Figures and 152 Tables)

    • Figure Product Picture

    • Figure Europe Prophylactic Pediatric Vaccines Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Europe Prophylactic Pediatric Vaccines Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Europe Prophylactic Pediatric Vaccines Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Europe Prophylactic Pediatric Vaccines Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Europe Prophylactic Pediatric Vaccines Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Europe Prophylactic Pediatric Vaccines Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Germany Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure UK Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure France Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Prophylactic Pediatric Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Prophylactic Pediatric Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Prophylactic Pediatric Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Prophylactic Pediatric Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of Prophylactic Pediatric Vaccines by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Prophylactic Pediatric Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Prophylactic Pediatric Vaccines by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Europe Prophylactic Pediatric Vaccines Production by Major Regions

    • Table Europe Prophylactic Pediatric Vaccines Production Share by Major Regions

    • Figure Europe Prophylactic Pediatric Vaccines Production Share by Major Countries and Regions in 2014

    • Table Europe Prophylactic Pediatric Vaccines Consumption by Major Regions

    • Table Europe Prophylactic Pediatric Vaccines Consumption Share by Major Regions

    • Table Germany Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

    • Table UK Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

    • Table France Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

    • Table Italy Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

    • Table Spain Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

    • Table Poland Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

    • Table Russia Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

    • Table Switzerland Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

    • Table Turkey Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Pediatric Vaccines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Prophylactic Pediatric Vaccines Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Prophylactic Pediatric Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Prophylactic Pediatric Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Prophylactic Pediatric Vaccines Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Prophylactic Pediatric Vaccines Consumption by Types from 2014 to 2026

    • Table Germany Prophylactic Pediatric Vaccines Consumption Share by Types from 2014 to 2026

    • Table Germany Prophylactic Pediatric Vaccines Consumption by End-Users from 2014 to 2026

    • Table Germany Prophylactic Pediatric Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table UK Prophylactic Pediatric Vaccines Consumption by Types from 2014 to 2026

    • Table UK Prophylactic Pediatric Vaccines Consumption Share by Types from 2014 to 2026

    • Table UK Prophylactic Pediatric Vaccines Consumption by End-Users from 2014 to 2026

    • Table UK Prophylactic Pediatric Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table France Prophylactic Pediatric Vaccines Consumption by Types from 2014 to 2026

    • Table France Prophylactic Pediatric Vaccines Consumption Share by Types from 2014 to 2026

    • Table France Prophylactic Pediatric Vaccines Consumption by End-Users from 2014 to 2026

    • Table France Prophylactic Pediatric Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Italy Prophylactic Pediatric Vaccines Consumption by Types from 2014 to 2026

    • Table Italy Prophylactic Pediatric Vaccines Consumption Share by Types from 2014 to 2026

    • Table Italy Prophylactic Pediatric Vaccines Consumption by End-Users from 2014 to 2026

    • Table Italy Prophylactic Pediatric Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Spain Prophylactic Pediatric Vaccines Consumption by Types from 2014 to 2026

    • Table Spain Prophylactic Pediatric Vaccines Consumption Share by Types from 2014 to 2026

    • Table Spain Prophylactic Pediatric Vaccines Consumption by End-Users from 2014 to 2026

    • Table Spain Prophylactic Pediatric Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Poland Prophylactic Pediatric Vaccines Consumption by Types from 2014 to 2026

    • Table Poland Prophylactic Pediatric Vaccines Consumption Share by Types from 2014 to 2026

    • Table Poland Prophylactic Pediatric Vaccines Consumption by End-Users from 2014 to 2026

    • Table Poland Prophylactic Pediatric Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Russia Prophylactic Pediatric Vaccines Consumption by Types from 2014 to 2026

    • Table Russia Prophylactic Pediatric Vaccines Consumption Share by Types from 2014 to 2026

    • Table Russia Prophylactic Pediatric Vaccines Consumption by End-Users from 2014 to 2026

    • Table Russia Prophylactic Pediatric Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Prophylactic Pediatric Vaccines Consumption by Types from 2014 to 2026

    • Table Switzerland Prophylactic Pediatric Vaccines Consumption Share by Types from 2014 to 2026

    • Table Switzerland Prophylactic Pediatric Vaccines Consumption by End-Users from 2014 to 2026

    • Table Switzerland Prophylactic Pediatric Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Prophylactic Pediatric Vaccines Consumption by Types from 2014 to 2026

    • Table Turkey Prophylactic Pediatric Vaccines Consumption Share by Types from 2014 to 2026

    • Table Turkey Prophylactic Pediatric Vaccines Consumption by End-Users from 2014 to 2026

    • Table Turkey Prophylactic Pediatric Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Pediatric Vaccines Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Pediatric Vaccines Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Pediatric Vaccines Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Pediatric Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Pediatric Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Pediatric Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Prophylactic Pediatric Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Prophylactic Pediatric Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Prophylactic Pediatric Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Prophylactic Pediatric Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Prophylactic Pediatric Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Pediatric Vaccines Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Pediatric Vaccines Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Pediatric Vaccines Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Pediatric Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Pediatric Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Pediatric Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Prophylactic Pediatric Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Prophylactic Pediatric Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Prophylactic Pediatric Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Pediatric Vaccines Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Pediatric Vaccines Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Pediatric Vaccines Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Pediatric Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Pediatric Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Pediatric Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Prophylactic Pediatric Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Prophylactic Pediatric Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Prophylactic Pediatric Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of GlaxoSmithKline Plc (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc (UK)

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc (UK)

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc (UK)

    • Table Product and Service Introduction of GlaxoSmithKline Plc (UK)

    • Table Company Profile and Development Status of Sanofi Pasteur SA (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur SA (France)

    • Figure Sales and Growth Rate Analysis of Sanofi Pasteur SA (France)

    • Figure Revenue and Market Share Analysis of Sanofi Pasteur SA (France)

    • Table Product and Service Introduction of Sanofi Pasteur SA (France)

    • Table Company Profile and Development Status of Bharat Biotech International Limited (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bharat Biotech International Limited (India)

    • Figure Sales and Growth Rate Analysis of Bharat Biotech International Limited (India)

    • Figure Revenue and Market Share Analysis of Bharat Biotech International Limited (India)

    • Table Product and Service Introduction of Bharat Biotech International Limited (India)

    • Table Company Profile and Development Status of Hualan Biological Engineering Inc. (China)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Biological Engineering Inc. (China)

    • Figure Sales and Growth Rate Analysis of Hualan Biological Engineering Inc. (China)

    • Figure Revenue and Market Share Analysis of Hualan Biological Engineering Inc. (China)

    • Table Product and Service Introduction of Hualan Biological Engineering Inc. (China)

    • Table Company Profile and Development Status of Janssen Pharmaceuticals, Inc. (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceuticals, Inc. (US)

    • Figure Sales and Growth Rate Analysis of Janssen Pharmaceuticals, Inc. (US)

    • Figure Revenue and Market Share Analysis of Janssen Pharmaceuticals, Inc. (US)

    • Table Product and Service Introduction of Janssen Pharmaceuticals, Inc. (US)

    • Table Company Profile and Development Status of Pfizer Inc. (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc. (US)

    • Figure Sales and Growth Rate Analysis of Pfizer Inc. (US)

    • Figure Revenue and Market Share Analysis of Pfizer Inc. (US)

    • Table Product and Service Introduction of Pfizer Inc. (US)

    • Table Company Profile and Development Status of SK Chemicals Co., Ltd. (Korea)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SK Chemicals Co., Ltd. (Korea)

    • Figure Sales and Growth Rate Analysis of SK Chemicals Co., Ltd. (Korea)

    • Figure Revenue and Market Share Analysis of SK Chemicals Co., Ltd. (Korea)

    • Table Product and Service Introduction of SK Chemicals Co., Ltd. (Korea)

    • Table Company Profile and Development Status of ALK - Abello A/S (Denmark)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ALK - Abello A/S (Denmark)

    • Figure Sales and Growth Rate Analysis of ALK - Abello A/S (Denmark)

    • Figure Revenue and Market Share Analysis of ALK - Abello A/S (Denmark)

    • Table Product and Service Introduction of ALK - Abello A/S (Denmark)

    • Table Company Profile and Development Status of Altimmune, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altimmune, Inc (US)

    • Figure Sales and Growth Rate Analysis of Altimmune, Inc (US)

    • Figure Revenue and Market Share Analysis of Altimmune, Inc (US)

    • Table Product and Service Introduction of Altimmune, Inc (US)

    • Table Company Profile and Development Status of Merck & Co., Inc. (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co., Inc. (US)

    • Figure Sales and Growth Rate Analysis of Merck & Co., Inc. (US)

    • Figure Revenue and Market Share Analysis of Merck & Co., Inc. (US)

    • Table Product and Service Introduction of Merck & Co., Inc. (US)

    • Table Company Profile and Development Status of Altimmune, Inc. (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altimmune, Inc. (US)

    • Figure Sales and Growth Rate Analysis of Altimmune, Inc. (US)

    • Figure Revenue and Market Share Analysis of Altimmune, Inc. (US)

    • Table Product and Service Introduction of Altimmune, Inc. (US)

    • Table Company Profile and Development Status of GlaxoSmithKline Plc. (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc. (UK)

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc. (UK)

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc. (UK)

    • Table Product and Service Introduction of GlaxoSmithKline Plc. (UK)

    • Table Company Profile and Development Status of BiondVax Pharmaceuticals Ltd. (Israel)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BiondVax Pharmaceuticals Ltd. (Israel)

    • Figure Sales and Growth Rate Analysis of BiondVax Pharmaceuticals Ltd. (Israel)

    • Figure Revenue and Market Share Analysis of BiondVax Pharmaceuticals Ltd. (Israel)

    • Table Product and Service Introduction of BiondVax Pharmaceuticals Ltd. (Israel)

    • Table Company Profile and Development Status of Shanghai BravoBio Co., Ltd. (China)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai BravoBio Co., Ltd. (China)

    • Figure Sales and Growth Rate Analysis of Shanghai BravoBio Co., Ltd. (China)

    • Figure Revenue and Market Share Analysis of Shanghai BravoBio Co., Ltd. (China)

    • Table Product and Service Introduction of Shanghai BravoBio Co., Ltd. (China)

    • Table Company Profile and Development Status of Serum Institute of India Pvt. Ltd. (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute of India Pvt. Ltd. (India)

    • Figure Sales and Growth Rate Analysis of Serum Institute of India Pvt. Ltd. (India)

    • Figure Revenue and Market Share Analysis of Serum Institute of India Pvt. Ltd. (India)

    • Table Product and Service Introduction of Serum Institute of India Pvt. Ltd. (India)

    • Table Company Profile and Development Status of Seqirus (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seqirus (UK)

    • Figure Sales and Growth Rate Analysis of Seqirus (UK)

    • Figure Revenue and Market Share Analysis of Seqirus (UK)

    • Table Product and Service Introduction of Seqirus (UK)

    • Table Company Profile and Development Status of BiondVax Pharmaceuticals Ltd (Israel)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BiondVax Pharmaceuticals Ltd (Israel)

    • Figure Sales and Growth Rate Analysis of BiondVax Pharmaceuticals Ltd (Israel)

    • Figure Revenue and Market Share Analysis of BiondVax Pharmaceuticals Ltd (Israel)

    • Table Product and Service Introduction of BiondVax Pharmaceuticals Ltd (Israel)

    • Table Company Profile and Development Status of Shanghai BravoBio Co, Ltd (China)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai BravoBio Co, Ltd (China)

    • Figure Sales and Growth Rate Analysis of Shanghai BravoBio Co, Ltd (China)

    • Figure Revenue and Market Share Analysis of Shanghai BravoBio Co, Ltd (China)

    • Table Product and Service Introduction of Shanghai BravoBio Co, Ltd (China)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US